SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: alex e. karczewski who wrote ()4/10/1997 1:09:00 PM
From: Dave Chapman   of 211
 
Re todays earnings (.03)vs(.51) qtr/qtr & (.07)vs(.83) 9mos/9mos

biz.yahoo.com

I am curious about the move from "sales" to "guaranteed payments"
Im sure it relates to the Ethicon agreement but how does it affect
revenue next month?

3 Months 9 Months
March 31, March 31,
1997 1996 1997 1996
Sales $ 693 $ 1,713 $ 3,524 $ 3,421
Guaranteed Payments 1,480 - 2,980 -
2,173 1,713 6,504 3,421
Cost of Sales 397 734 1,749 1,654
Gross Profit 1,776 979 4,755 1,767
Operating Expenses:
Research and
development 581 384 1,527 864
Sales and marketing 1,216 825 3,419 2,578
General and
administrative 1,044 414 2,597 1,120
Write-off of
acquired in-process
research and
development - 2,791 - 2,791
Total operating
expenses 2,841 4,414 7,543 7,353
Operating loss (1,065) (3,435) (2,788) (5,586)
Interest and other
income (expense) 626 63 1,883 151
Net loss $ (439) $ (3,372) $ (905) $ (5,435)
Net loss per share $(0.03) $ (0.51) $(0.07) $ (0.83) 97 96 97 96
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext